| Cat. No. | Product Name | Target | Signaling Pathways |
|---|---|---|---|
| T20167 |
Cilazapril
西拉普利,Cilazapril (anhydrous),Ro 34-2848,Ro34-2848,Ro-34-2848 |
||
| Cilazapril is an angiotensin-converting enzyme inhibitor. It has been researched for mild to moderate essential hypertension. | |||
| T68435 | Cilazapril HCl | ||
| Cilazapril, also known as Ro 31 2848, is a potent ACE inhibitor used for hypertension. Cilazapril is a prodrug that is hydrolyzed after absorption to its main metabolite cilazaprilat. Cilazapril is a monoethyl ester, which acts as an angiotensin-converting enzyme (ACE) inhibitor. The inhibitor functions by inhibiting the ability of ACE to cleave bonds of angiotensin I and Hip-His-Leu. It is known that the diacid form of Cilazapril is more potent that enalapril at inhibiting ACE. | |||
| T6444 |
Cilazapril Monohydrate
Ro 31-2848 monohydrate,Justor,西拉普利水合物,西拉普利 |
RAAS | Endocrinology/Hormones |
| Cilazapril Monohydrate 是一种血管紧张素转化酶抑制剂，能够作用于高血压和充血性心力衰竭的研究。 | |||
| T68412 | Cilazaprilat | ||
| Cilazaprilat is the active metabolite of cilazapril, a pyridazine angiotensin-converting enzyme (ACE) inhibitor with antihypertensive activity. | |||
沪公网安备 31010602006700号
